Factors Predisposing to Hypertension in Subjects Formerly Born Preterm: Renal Impairment, Arterial Stiffness,

Antonio Crisafulli1, Pier P Bassareo2, Sean Kelleher2

  • 1Department of Medical Sciences and Public Health, Sports Physiology Laboratory, University of Cagliari, Cagliari, Italy.

Insights

Individuals born preterm have a higher risk of developing arterial hypertension. This review explores mechanisms like reduced nephrons, arterial rigidity, and impaired nitric oxide pathways contributing to elevated blood pressure in preterm infants.

Area of Science:

  • Cardiovascular Physiology
  • Nephrology
  • Developmental Pediatrics

Background:

  • Individuals born preterm exhibit a higher incidence of arterial hypertension compared to term-born peers.
  • This predisposition is linked to several physiological alterations originating during fetal development.

Purpose of the Study:

  • To comprehensively review the multifactorial mechanisms underlying hypertension in individuals born preterm or with intrauterine growth restriction.
  • To discuss emerging laboratory techniques for identifying metabolic alterations related to blood pressure regulation.

Main Methods:

  • Literature review of studies investigating cardiovascular and renal development in preterm infants.
  • Analysis of factors contributing to increased blood pressure, including nephrogenesis, arterial elasticity, and endothelial function.
  • Exploration of the role of ADMA and the renin-angiotensin-aldosterone system.

Main Results:

  • Incomplete nephrogenesis leads to fewer nephrons, reduced filtration, and increased sodium reabsorption.
  • Elastin deficiency in the aorta contributes to arterial rigidity and elevated systolic blood pressure.
  • Reduced nitric oxide bioavailability, exacerbated by elevated ADMA levels, promotes vasoconstriction.

Conclusions:

  • Multiple developmental factors converge to increase hypertension risk in preterm individuals.
  • Understanding these mechanisms is crucial for early detection and intervention strategies.
  • Metabolomics offers a promising avenue for identifying novel biomarkers and therapeutic targets.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
433
The Born-Haber Cycle02:44

The Born-Haber Cycle

Lattice Energy 
25.2K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
578
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
445
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
475
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
518